Physician profile
Anna M David
NPI 1518407840
$1,134.43
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,037 · 2023: $97.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $97.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $97.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $211.18 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $200.20 | 2021 | |
| Abbvie INC. | $196.70 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $119.25 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $97.14 | 2023 | |
| Pfizer INC. | $55.61 | 2021 | |
| Ironwood Pharmaceuticals, INC | $51.69 | 2021 | |
| Qol Medical, LLC | $47.01 | 2021 | |
| Nestle Healthcare Nutrition INC. | $28.06 | 2021 | |
| Gilead Sciences, INC. | $25.57 | 2021 | |
| Redhill Biopharma INC. | $18.47 | 2021 | |
| Amgen INC. | $18.25 | 2021 | |
| Ucb, INC. | $17.34 | 2021 | |
| Braintree Laboratories, INC. | $17.29 | 2021 | |
| Intercept Pharmaceuticals, INC. | $15.73 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $14.94 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna David listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.